Zafirlukast protects blood-brain barrier integrity from ischemic brain injury
- PMID: 31816286
- DOI: 10.1016/j.cbi.2019.108915
Zafirlukast protects blood-brain barrier integrity from ischemic brain injury
Abstract
Stroke has been considered the second leading cause of death worldwide, and ischemic stroke accounts for the vast majority of stroke cases. Some of the main features of ischemic stroke are increased brain permeability, ischemia/reperfusion injury, oxidative stress, and acute inflammation. Antagonism of cysLT1R has been shown to provide cardiovascular and neural benefits. In the present study, we investigated the effects of the cysLT1R antagonist zafirlukast both in vivo and in vitro using a middle cerebral artery occlusion (MCAO) mouse model and human brain microvascular endothelial cells (HBMVECs). In vivo, we found that zafirlukast pretreatment could reduce MCAO-induced increased brain permeability by rescuing the expression levels of the tight junction proteins occludin and ZO-1. In vitro, we found that zafirlukast could suppress the increase in endothelial monolayer permeability induced by OGD/R via rescue of occludin and ZO-1 expression; additionally, we found that zafirlukast prevented OGD/R-induced degradation of the extracellular matrix via inhibition of MMP-2 and MMP-9 expression. Finally, we found that zafirlukast could also inhibit OGD/R-induced activation of the critical proinflammatory regulator NF-κB by preventing phosphorylation and nuclear translocation of p65 protein. Together, our findings demonstrate a promising role for zafirlukast in preventing damage induced by ischemic stroke and reperfusion injury.
Keywords: Brain endothelial cells; Brain permeability; NF-κB; Tight junction; ZO-1; Zafirlukast.
Copyright © 2019. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Lifibrate attenuates blood-brain barrier damage following ischemic stroke via the MLCK/p-MLC/ZO-1 axis.Aging (Albany NY). 2024 Mar 27;16(7):6135-6146. doi: 10.18632/aging.205692. Epub 2024 Mar 27. Aging (Albany NY). 2024. PMID: 38546384 Free PMC article.
-
Ulinastatin protects brain against cerebral ischemia/reperfusion injury through inhibiting MMP-9 and alleviating loss of ZO-1 and occludin proteins in mice.Exp Neurol. 2018 Apr;302:68-74. doi: 10.1016/j.expneurol.2017.12.016. Epub 2017 Dec 30. Exp Neurol. 2018. PMID: 29291404
-
The neurovascular protective effect of alogliptin in murine MCAO model and brain endothelial cells.Biomed Pharmacother. 2019 Jan;109:181-187. doi: 10.1016/j.biopha.2018.10.064. Epub 2018 Nov 2. Biomed Pharmacother. 2019. PMID: 30396075
-
Therapeutic Potentials of MicroRNA-126 in Cerebral Ischemia.Mol Neurobiol. 2023 Apr;60(4):2062-2069. doi: 10.1007/s12035-022-03197-4. Epub 2023 Jan 4. Mol Neurobiol. 2023. PMID: 36596965 Review.
-
Roles of blood-brain barrier integrins and extracellular matrix in stroke.Am J Physiol Cell Physiol. 2019 Feb 1;316(2):C252-C263. doi: 10.1152/ajpcell.00151.2018. Epub 2018 Nov 21. Am J Physiol Cell Physiol. 2019. PMID: 30462535 Free PMC article. Review.
Cited by
-
Zafirlukast, as a viral inactivator, potently inhibits infection of several flaviviruses, including Zika virus, dengue virus, and yellow fever virus.Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0016824. doi: 10.1128/aac.00168-24. Epub 2024 May 29. Antimicrob Agents Chemother. 2024. PMID: 38809067 Free PMC article.
-
Stroke-induced damage on the blood-brain barrier.Front Neurol. 2023 Sep 28;14:1248970. doi: 10.3389/fneur.2023.1248970. eCollection 2023. Front Neurol. 2023. PMID: 37840921 Free PMC article. Review.
-
Post-acute ischemic stroke hyperglycemia aggravates destruction of the blood-brain barrier.Neural Regen Res. 2024 Jun 1;19(6):1344-1350. doi: 10.4103/1673-5374.385851. Epub 2023 Sep 22. Neural Regen Res. 2024. PMID: 37905884 Free PMC article.
-
miR-671-5p Upregulation Attenuates Blood-Brain Barrier Disruption in the Ischemia Stroke Model Via the NF-кB/MMP-9 Signaling Pathway.Mol Neurobiol. 2023 Jul;60(7):3824-3838. doi: 10.1007/s12035-023-03318-7. Epub 2023 Mar 22. Mol Neurobiol. 2023. PMID: 36949221
-
Lifibrate attenuates blood-brain barrier damage following ischemic stroke via the MLCK/p-MLC/ZO-1 axis.Aging (Albany NY). 2024 Mar 27;16(7):6135-6146. doi: 10.18632/aging.205692. Epub 2024 Mar 27. Aging (Albany NY). 2024. PMID: 38546384 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous